ESR1 and breast cancer: Consistent with the findings by Rakha et al,7 our findings suggest that single hormone receptor–positive BC has a prognosis midway between that of the ER-positive/PR-positive and ER-negative/PR-negative subtypes; however, we also observed that ER loss appeared to be statistically significantly associated with worse BCSS and OS than PR loss.